Related Experiment Video
Updated: May 4, 2026

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
The 3xTg-AD Mouse Model: A Comprehensive Tool for Understanding Alzheimer's Disease.
Arindam Pattanayak1, Sayed Mohammed Firdous2
1Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and AHS, Uluberia, Howrah, West Bengal, 711316, India.
The triple-transgenic mouse (3xTg-AD) model effectively mimics Alzheimer's disease (AD) pathologies and cognitive decline. This versatile model aids in evaluating novel Alzheimer's disease therapies and understanding disease mechanisms.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by amyloid-beta (Aβ) plaques, neurofibrillary tangles (NFTs), and cognitive impairment.
- Animal models are essential for studying AD pathogenesis and testing therapeutic interventions.
- The triple-transgenic mouse (3xTg-AD) model overexpresses human AD-linked genes (tau, PSEN1, APP), recapitulating key pathological features.
Purpose of the Study:
- To review the utility and translational potential of the 3xTg-AD mouse model for Alzheimer's disease research.
- To highlight the model's capacity for studying AD pathophysiology, including amyloid and tau deposition, neuroinflammation, and cognitive deficits.
- To assess the model's application in evaluating preclinical therapeutic strategies and identifying biomarkers.
Main Methods:
- Genetic engineering of mice to overexpress human tau, PSEN1, and APP.
- Longitudinal monitoring of pathological hallmarks (Aβ, NFTs) and behavioral deficits (cognitive, anxiety, depression).
- Evaluation of therapeutic interventions including immunotherapy, nutraceuticals (resveratrol), and lifestyle modifications.
Main Results:
- 3xTg-AD mice exhibit age-dependent development of intracellular Aβ, extracellular plaques, and NFTs, mirroring human AD.
- The model displays synaptic dysfunction, neuroinflammation, cognitive deficits, and non-cognitive symptoms.
- The model has shown promise in preclinical studies for assessing treatments aimed at reducing Aβ and tau pathology and improving cognition.
Conclusions:
- The 3xTg-AD mouse is a valuable and versatile preclinical model for Alzheimer's disease research.
- Its ability to replicate key AD pathologies and behavioral phenotypes supports its use in evaluating therapeutic strategies.
- Further integration with multi-omics and human iPSC systems can enhance the translational relevance of findings from this model.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017